Clinical Trials Browser

decitabine and cedazuridine drug combination × Dermatologic × 90 days × Clear all

NCT07472322 2026-05-29

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Phase 1/2 Not yet recruiting

Carcinoma, Merkel Cell